Ticker Details
Kymera Therapeutics, Inc.
IPO Date:	August 21, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$10.1B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.38 | 3.28%
Avg Daily Range (30 D):	$2.63 | 2.36%
Avg Daily Range (90 D):	$2.42 | 2.55%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.51M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	54
Avg Trade Size (Sh.) (30 D):	44
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	2,825
Avg Institutional Trade:	$3.11M
Avg Institutional Trade (30 D):	$11.2M
Avg Institutional Trade (90 D):	$7.2M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.37M
Avg Closing Trade (30 D):	$11.71M
Avg Closing Trade (90 D):	$12.05M
Avg Closing Volume:	96.92K

News

Jul 12, 2026 @ 8:37 PM Kymera's CEO Sold $6 Million in Stock After a 170%... Source: Jonathan Ponciano

Jun 12, 2026 @ 11:00 AM Kymera Therapeutics Presents Phase 1 Data in Healt... Source: Na

Jun 8, 2026 @ 11:00 AM Kymera Therapeutics Presents New Preclinical Lupus... Source: Kymera Therapeutics

May 15, 2026 @ 11:00 AM Kymera Therapeutics Announces Presentations on KT-... Source: Na

May 6, 2026 @ 11:00 AM Kymera Therapeutics to Participate in Upcoming May... Source: Not Specified

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-3.25	$-.62	$-.71
Diluted EPS	$-3.25	$-.62	$-.71
Revenue	$105M	$65M	$34.37M
Gross Profit	$M	$M	$M
Net Income / Loss	$-299.6M	$-61.21M	$-69.23M
Operating Income / Loss	$-350.18M	$-75.61M	$-84.16M
Cost of Revenue	$105M	$65M	$34.37M
Net Cash Flow	$-211.34M
PE Ratio